End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.27 CNY | +1.63% | +14.62% | +12.30% |
22/04 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
Sales 2024 * | 3.09B 427M 35.6B | Sales 2025 * | 4.05B 559M 46.66B | Capitalization | 48.14B 6.65B 555B |
---|---|---|---|---|---|
Net income 2024 * | 806M 111M 9.29B | Net income 2025 * | 1.06B 146M 12.21B | EV / Sales 2024 * | 15.1 x |
Net cash position 2024 * | 1.57B 217M 18.07B | Net cash position 2025 * | 5B 691M 57.6B | EV / Sales 2025 * | 10.7 x |
P/E ratio 2024 * |
59.9
x | P/E ratio 2025 * |
46.9
x | Employees | 1,887 |
Yield 2024 * |
0.78% | Yield 2025 * |
0.38% | Free-Float | 22.71% |
1 day | +1.63% | ||
1 week | +14.62% | ||
Current month | +11.15% | ||
1 month | +11.15% | ||
3 months | +46.50% | ||
6 months | +49.38% | ||
Current year | +12.30% |
Managers | Title | Age | Since |
---|---|---|---|
Feng Han
CEO | Chief Executive Officer | 50 | 01/16/01 |
Long Dai
DFI | Director of Finance/CFO | 32 | 07/23/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Dong Pan
CHM | Chairman | 55 | - |
Huai Yu Wang
BRD | Director/Board Member | 61 | 01/16/01 |
Ji Yong Zhang
CHM | Chairman | - | 01/16/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 34.27 | +1.63% | 8,332,086 |
29/24/29 | 33.72 | +0.27% | 8,961,974 |
26/24/26 | 33.63 | +0.99% | 9,847,105 |
25/24/25 | 33.3 | +3.44% | 13,140,460 |
24/24/24 | 32.19 | +5.26% | 15,204,143 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.30% | 6.65B | |
+13.21% | 8.15B | |
-0.47% | 7.27B | |
-6.99% | 3.72B | |
-6.49% | 3.67B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-12.13% | 876M | |
-38.53% | 866M | |
-18.31% | 786M |
- Stock Market
- Equities
- 300765 Stock